← Browse by Condition
Medical Condition

igg4 related diseases

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06794008 Phase 2
Recruiting

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

Enrollment
50 pts
Location
China
Sponsor
Peking University People's Hos...
View Trial →